Created with Sketch.
Lung Cancer Considered
37 minutes | Jan 18, 2022
Cell Therapy With Ben Creelan And Prasad Adusumilli
Cell therapy has made strides in hematology and oncology and has recently shown promise in thoracic oncology. In this episode of Lung Cancer Considered host, Dr. Narjust Duma delves into this emerging therapy with guests Dr. Ben Creelan, associate professor of medicine at the University of South Florida, thoracic oncologist at Moffitt Cancer Center and Dr. Prasad Adusumilli, deputy chief and attending of the thoracic service, vice chair for translational research in the department of surgery at Memorial Sloan Kettering Cancer Center.
44 minutes | Jan 4, 2022
Virtual Tumor Board EGFR With Helena Yu And Alfredo Addeo
This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cough, chest pain, and weight loss. Discussing treatment options on this podcast with host Dr. Narjust Duma are Dr. Alfredo Addeo, senior oncologist at Geneva Hospital in Geneva, Switzerland, and Dr. Helena Yu, medical oncologist at Memorial Sloan Kettering Cancer Center in New York City.
42 minutes | Dec 28, 2021
Breakthrough Therapies - NRG1 with Dr. Laskin and Dr. Cadranel
Dr. Jacques Cadranel, Head of Department Pulmonology and Thoracic Oncology, Assistance Publique Hôpitaux de Paris and Sorbonne University and Dr Janessa Laskin, Medical Oncologist at the Vancouver Cancer Centre in British Columbia, Canada join Lung Cancer Considered Host Dr. Narjust Duma to discuss current and promising breakthrough therapies in lung cancer.
37 minutes | Dec 21, 2021
LALCA 2021 Highlights With Luis E. Raez Christian Rolfo Lucia Viola
Dr. Narjust Duma hosts a spirited Spanish-language edition of Lung Cancer Considered on the recently completed 2021 LALCA Schools of Thoracic Oncology meeting with Luis E. Raez, MD, Chief Scientific Officer & Medical Director Memorial Cancer Institute/Memorial Health Care System; Lucia Viola, MD, Interventional Pulmonologist, Head of Thoracic Oncology Service, Fundación Neumológica Colombiana and Christian Rolfo, MD, PhD, Professor and Assoc. Director for Clinical Research, Center for Thoracic Oncology- Icahn School of Medicine at Mount Sinai. La Dra. Narjust Duma presenta una animada edición en español de Lung Cancer Considered durante la reunión de las Escuelas de Oncología Torácica LALCA 2021 recientemente completada, con el Dr. Luis E. Raez, Director Científico y Médico del Memorial Cancer Institute / Memorial Health Care System; Dra. Lucia Viola, Neumóloga Intervencionista, Jefa del Servicio de Oncología Torácica, Fundación Neumológica Colombiana y el Dr. Christian Rolfo, Profesor y Asociado. Director de Investigación Clínica, Centro de Oncología Torácica - Facultad de Medicina Icahn en Mount Sinai.
41 minutes | Dec 7, 2021
Virtual Tumor Board NSCLC - Anthony Kim And Patricia Rivera
Lung Cancer Considered host Dr. Stephen Liu discusses a virtual tumor board with guests Dr. Anthony Kim, professor of clinical surgery and chief of thoracic surgery at The Keck School of Medicine at the University of Southern California and Dr. Patricia Rivera, professor of medicine at University of North Carolina and director of the UNC Lung Cancer Screening Initiative. The case involves a 45-year-old woman with stage III non-small cell lung cancer.
40 minutes | Dec 1, 2021
IASLC Stars - Lillian Leigh, Erika Hlavacek, Caleb Egwuenu
In this new episode of Lung Cancer Considered, podcast host Dr. Narjust Duma interviews three IASLC Patient Research Advocates who are part of the IASLC Supportive Training for Advocates on Research & Science (STARS) program: Caleb Egwuenu comes from Nigeria and participated in STARS for two years as a Patient Research Advocate: Erika Hlavacek, a Patient Research Advocate and founder of nonprofit yEAHbestlife from Illinois; and Lillian Leigh, STARS mentor from Australia.
29 minutes | Nov 30, 2021
Global Advocacy - Dr. Anne-Marie Baird
Globally, lung cancer is the single most lethal cancer, accounting for 1.8 million deaths last year, yet research funding devoted to lung cancer pales in comparison to other cancer types. In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses how global advocacy might play a role in addressing this gap. His guest is Dr. Anne-Marie Baird, a cancer researcher at Trinity College in Dublin, Ireland. Dr. Baird is the former Chair of the IASLC Communications Committee, and the newly appointed President of Lung Cancer Europe, a European platform for lung cancer advocacy.
50 minutes | Nov 22, 2021
Lung Cancer in Korea - Chul Kim, Young Tae Kim and Sun Min Lim
In a special Korean-language Lung Cancer Considered episode, leading lung cancer specialists discuss the state of the disease in South Korea. Host Dr. Chul Kim, assistant professor of Medicine and Thoracic Medical Oncologist at Georgetown University, interviews Dr. Young Tae Kim, professor of the Department of Thoracic and Cardiovascular Surgery, Seoul National University College of Medicine and Dr. Sun Min Lim, assistant professor of the Department of Internal Medicine, Yonsei University College of Medicine. The podcast will be released in conjunction with the annual meeting of the Korean Association for Lung Cancer held on November 25-26, 2021 in Seoul, South Korea (https://www.kalcic.or.kr/main.php). 세계폐암학회에서 주관하는 팟캐스트인 'Lung Cancer Considered'에서 폐암 전문가들을 모시고 한국 특별편을 준비하였습니다. 조지타운대학교 암센터에서 폐암 전문의로 근무하고 있는 김철 교수가 서울대학교병원 흉부외과 김영태 교수님과 연세대학교 의과대학 내과학교실 종양내과 임선민 교수님을 모시고 인터뷰를 진행하였습니다. 이번 한국 특별편 팟캐스트는 11월 25일과 26일에 서울에서 열리는 대한폐암학회 국제학술대회 (https://www.kalcic.or.kr/main.php)에 맞춰 공개될 예정입니다.
41 minutes | Nov 22, 2021
Virtual Tumor Board NSCLC - Stephen Liu Erin Gillaspie And Shankar Siva
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a virtual tumor board case focusing on a patient with stage III NSCLC. Guests are Dr. Erin Gillaspie, assistant professor of Thoracic Surgery at Vanderbilt University in Nashville, Tenn., and Dr. Shankar Siva, associate professor at the University of Melbourne, in Victoria, Australia.
28 minutes | Nov 9, 2021
Lung Cancer Advocate and Pro Golfer - Jason Day
Professional Golfer Jason Day has known success in his career--he has been the top ranked PGA player and won the PGA Championship in 2015. Unfortunately, that year Jason’s mother Denning was diagnosed with state IV non-small-cell lung cancer, spurring Jason to become a passionate advocate for lung cancer research and treatment. Tune into this episode of Lung Cancer Considered to hear about how he became a lung cancer advocate and how his mother’s health drove him to become an advocate for biomarker testing.
54 minutes | Oct 30, 2021
White Ribbon Project - Heidi Nafman-Onda, Dr. Pierre Onda and Chris Draft
In this episode of Lung Cancer Considered, host Dr. Narjust Duma talks with Heidi Nafman-Onda and her husband Dr. Pierre Onda, the founders of The White Ribbon project, and patient advocate/activist Chris Draft from the Chris Draft Family Foundation.
26 minutes | Oct 26, 2021
SCLC Research - Charles Rudin and Tripnara Sen
This episode of Lung Cancer Considered looks ahead to the IASLC 2021 Hot Topic Meeting on Small Cell Lung Cancer, scheduled for Oct 29th and 30th 2021. Host Dr. Stephen Liu discusses the state of the SCLC research with Dr. Tripnara Sen, an Assistant Attending Biologist in the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center and Dr. Charles Rudin, the co-director of the Druckenmiller Center for Lung Cancer Research and the Sylvia Hassenfeld Chair in Lung Cancer Research, also from Memorial Sloan Kettering.
32 minutes | Oct 19, 2021
Tumor Board Discussion: SCLC with Lauren Byers and Santiago Ponce Aix
Tune in to Lung Cancer Considered as host Dr. Stephen Liu discusses a virtual tumor board case involving a patient with small cell lung cancer. Guests include Dr. Lauren Byers, associate professor of Medicine at The University of Texas MD Anderson Cancer Center, and Dr. Ponce Aix, from the Gustave Roussy in Paris, France.
32 minutes | Oct 14, 2021
ESMO Highlights - Solange Peters and Pasi Janne
In this episode of Lung Cancer Considered, podcast guests Dr. Solange Peters, current ESMO president, and Dr. Pasi Janne, co-chair of ESMO 2021, discuss the recently concluded ESMO meeting and share the meeting’s most significant lung cancer research findings with podcast host Dr. Narjust Duma.
49 minutes | Oct 6, 2021
Politics and Medicine/Cancer with Nasser Hanna and Raja Flores
The intersection of medicine and politics is fascinating and often controversial and contentious. In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks to two physicians who have entered the political arena—Dr. Nasser Hanna, who ran in Indiana’s 5th Congressional District and Dr. Raja Flores, who is running for Mayor of New York City.
42 minutes | Sep 18, 2021
Peer to Peer: Issues, Strategies and Impact with Dr. Nathan Pennell
In this episode of Lung Cancer Considered, Dr. Nathan Pennell, from the Cleveland Clinic, and Podcast host Dr. Narjust Duma, from Dana Farber Cancer Institute, share information about how lung cancer care has changed in the 14 years Dr. Pennell has been in practice.
45 minutes | Sep 15, 2021
2021 WCLC Highlights: Higgins, Harpole and Stinchcombe
The IASLC 2021 World Conference on Lung Cancer co-chairs Dr. David Harpole, Dr. Kristin Higgins, Dr. Thomas Stinchcombe join Lung Cancer Considered Hosts Dr. Narjust Duma and Dr. Stephen Liu to cover highlights of the recently concluded virtual meeting. Tune in to hear these IASLC members discuss the most significant research developments from the conference.
42 minutes | Sep 7, 2021
Meet Our President and President Elect - Heather Wakelee and Paul Van Schil
In this episode of Lung Cancer Considered , Dr. Heather Wakelee and Dr. Paul Van Schil join hosts Dr. Narjust Duma and Dr. Stephen Liu to discuss priorities and initiatives for IASLC in the 2021-22 year. Dr. Wakelee takes the reins as President of the IASLC this month during WCLC, the second woman to achieve this honor. Dr. Van Schil begins his term as President-Elect of the IASLC during WCLC, too.
40 minutes | Aug 31, 2021
Breakthrough Therapies - BRAF with Ibiayi Dagogo-Jack
In this episode of Lung Cancer Considered, host Dr. Narjust Duma and Dr. Ibiayo Dagogo discuss BRAF mutated non-small cell lung cancer and some unique characteristics of patients with this mutation.
39 minutes | Aug 17, 2021
Breakthrough Therapies- HER2 with Dr. Bob T. Li
About 20 percent of breast cancer cases have a link to the protein HER2, but HER2's link to lung cancer is not as common, and effective therapies have eluded lung cancer researchers. To learn more about the state of HER2 research for lung cancer, listen to this episode of Lung Cancer Considered with host Dr. Stephen Liu and Dr. Bob T. Li, Medical Oncologist from Memorial Sloan Kettering.
Terms of Service
Do Not Sell My Personal Information
© Stitcher 2022